Le rekkie del gold

Ciao ragazzacci, che ne dite ?

UAMY produce Antimonio e Zeolite che trasforma il metano in anidride carbonica, soluzione perfetta ai cambiamenti climatici prodotti dai gas serra nell’atmosfera.


 
La perfetta e unica rappresentazione di un'azione di merda, ma veramente di merda, si chiama Mux:




Data di rilascioFine PeriodoEPS/ PrevistoRicavi/ Previsto
11.03.202212/2021--/ 0,00--/ 42,52M
03.11.202109/2021-0,04/ 0,0037,1M/ 39,28M
04.08.202106/2021-0,01/ -0,01540,7M/ 38,65M
07.05.202103/2021-0,03/ -0,0323,72M/ 23,74M
11.03.202112/2020-0,06/ -0,01528,35M/ 28,88M
29.10.202009/2020-0,02/ -0,023327,4M/ 28,96M

Confermo e rilancio....!!!:d::rotfl::ombrello::ciapet:
 
ADMA Biologics Inc expected to post a loss of 14 cents a share - Earnings Preview
09 Nov 2021 03:11
* ADMA Biologics Inc <ADMA.OQ> <ADMA.O> is expected to show a
rise in quarterly revenue when it reports results on November
10.
* The Ramsey, New Jersey-based company is expected to report a
82.2% increase in revenue to $18.725 million from $10.28 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for ADMA Biologics Inc is
for a loss of 14 cents per share. For the same quarter last
year, the company reported a loss of 19 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for ADMA Biologics
Inc is $5, about 72.4% above its last closing price
of $1.38.
...
 

Users who are viewing this thread

Back
Alto